VerImmune Secures $4.5M in Pre-Series A Funding for Innovative Platform

Biotech startup VerImmune closes first phase of Pre-Series A funding, led by Beiley Biofund and joined by new investor Dr. John Ballantyne, PhD.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here